Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons
- PMID: 17706789
- PMCID: PMC2067253
- DOI: 10.1016/j.jneumeth.2007.06.022
Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons
Abstract
The poor survival rate (5-20%) of grafted embryonic dopamine (DA) neurons is one of the primary factors preventing cell replacement from becoming a viable treatment for Parkinson's disease. Previous studies have demonstrated that graft volume impacts grafted DA neuron survival, indicating that transplant parameters influence survival rates. However, the effects of mesencephalic cell concentration on grafted DA neuron survival have not been investigated. The current study compares the survival rates of DA neurons in grafts of varying concentrations. Mesencephalic cell suspensions derived from E14 Fisher 344 rat pups were concentrated to 25,000, 50,000, 100,000 and 200,000 cells/microl and transplanted into two 0.5 microl sites in the 6-OHDA-denervated rat striatum. Animals were sacrificed 10 days and 6 weeks post-transplantation for histochemical analysis of striatal grafts. The absolute number of DA neurons per graft increased proportionally to the total number of cells transplanted. However, our results show that the 200,000 cells/microl group exhibited significantly higher survival rates (5.48+/-0.83%) compared to the 25,000 cells/microl (2.81+/-0.39%) and 50,000 cells/microl (3.36+/-0.51%) groups (p=0.02 and 0.03, respectively). Soma size of grafted DA neurons in the 200,000 cells/microl group was significantly larger than that of the 25,000 cells/microl (p<0.0001) and 50,000 cells/microl groups (p=0.004). In conclusion, increasing the concentration of mesencephalic cells prior to transplantation, augments the survival and functionality of grafted DA neurons. These data have the potential to identify optimal transplantation parameters that can be applied to procedures utilizing stem cells, neural progenitors, and primary mesencephalic cells.
Figures






Similar articles
-
An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.Exp Neurol. 2004 May;187(1):58-64. doi: 10.1016/j.expneurol.2003.12.008. Exp Neurol. 2004. PMID: 15081588
-
Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.Exp Neurol. 2001 May;169(1):23-9. doi: 10.1006/exnr.2001.7644. Exp Neurol. 2001. PMID: 11312554
-
Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons.J Comp Neurol. 1998 Oct 5;399(4):530-40. doi: 10.1002/(sici)1096-9861(19981005)399:4<530::aid-cne6>3.0.co;2-2. J Comp Neurol. 1998. PMID: 9741481
-
How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?Neurosci Bull. 2007 Nov;23(6):377-82. doi: 10.1007/s12264-007-0056-4. Neurosci Bull. 2007. PMID: 18064069 Free PMC article. Review.
-
Transplants in Parkinson's disease.Eur Neurol. 1991;31 Suppl 1:17-27. doi: 10.1159/000116717. Eur Neurol. 1991. PMID: 1855521 Review.
Cited by
-
Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats.Cell Stem Cell. 2010 Mar 5;6(3):238-50. doi: 10.1016/j.stem.2010.01.004. Cell Stem Cell. 2010. PMID: 20207227 Free PMC article.
-
Engineering angiogenesis following spinal cord injury: a coculture of neural progenitor and endothelial cells in a degradable polymer implant leads to an increase in vessel density and formation of the blood-spinal cord barrier.Eur J Neurosci. 2009 Jan;29(1):132-45. doi: 10.1111/j.1460-9568.2008.06567.x. Eur J Neurosci. 2009. PMID: 19120441 Free PMC article.
-
Benefits and risks of intranigral transplantation of GABA-producing cells subsequent to the establishment of kindling-induced seizures.Neurobiol Dis. 2008 Sep;31(3):342-54. doi: 10.1016/j.nbd.2008.05.010. Epub 2008 Jul 15. Neurobiol Dis. 2008. PMID: 18632280 Free PMC article.
-
Cell therapy for Parkinson's disease: Why it doesn't work every time.Mov Disord. 2019 Aug;34(8):1120-1127. doi: 10.1002/mds.27742. Epub 2019 Jun 24. Mov Disord. 2019. PMID: 31234239 Free PMC article.
-
Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.Neurobiol Dis. 2015 May;77:191-203. doi: 10.1016/j.nbd.2015.03.005. Epub 2015 Mar 11. Neurobiol Dis. 2015. PMID: 25771169 Free PMC article.
References
-
- Abercrombie M. Estimation of nuclear populations from mictrotome sections. Anat Rec. 1946;94:239–247. - PubMed
-
- Bergman H, Deuschl G. Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord. 2002;17(Suppl 3):S28–40. - PubMed
-
- Brundin P, Strecker RE, Lindvall O, Isacson O, Nilsson OG, Barbin G, Prochiantz A, Forni C, Nieoullon A, Widner H, et al. Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease. Ann N Y Acad Sci. 1987;495:473–96. - PubMed
-
- Collier TJ, Sortwell CE. Therapeutic potential of nerve growth factors in Parkinson's disease. Drugs Aging. 1999;14:261–87. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical